跳转至内容
Merck
CN

918644

Low endotoxin gelatin solution

gel strength (bloom 300)

别名:

Type A, Bloom 300, Gelatin / GelMA & derivatives

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.23
UNSPSC Code:
12352202
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


form

viscous liquid

Quality Level

concentration

20 wt. % in DPBS (buffer)

impurities

<25 EU/mL Endotoxin, <5 cfu/mL Bioburden

color

colorless to pale yellow

pH

6.5-7.5

storage temp.

2-8°C

Application

Low endotoxin gelatin solution is a 20% low endotoxin gelatin solution in DPBS buffer. It is sterile filtrated through 0.2 μm sterile filter, and ready to be used in biomedical applications.

Gelatin is widely used for tissue engineering and 3D bioprinting. Gelatin is derived from natural extracellular matrix (ECM) components. Due to its low cost, abundance, and retention of natural cell binding motifs, gelatin has become a highly sought material for tissue engineering applications. Gelatin solution has thermoreversible gelling property which enables synthesis of biocompatible and biodegradable hydrogels and promote cell adhesion, spreading, and proliferation.

Packaging

10 mL in glass bottle


存储类别

10 - Combustible liquids

wgk

WGK 3

法规信息

低风险生物材料

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



J M Harlan et al.
Laboratory investigation; a journal of technical methods and pathology, 48(3), 269-274 (1983-03-01)
Lipopolysaccharide (LPS) produced time- and dose-dependent bovine endothelial cell injury in vitro that was manifested initially by cell detachment from culture substrate with subsequent cell lysis. Bovine endothelial cell injury was observed with LPS derived from Salmonella minnesota R595, a
K W Brunson et al.
Journal of supramolecular structure, 9(2), 231-242 (1978-01-01)
Chinese hamster ovary (CHO . K1 . PRO) cell growth was inhibited by addition of a gram-negative bacterial lipopolysaccharide (LPS) to the cell culture medium. Growth inhibition began after three or four days of incubation, was dose-dependent up to a
E J Ziegler et al.
The New England journal of medicine, 307(20), 1225-1230 (1982-11-11)
In an effort to decrease deaths from gram-negative bacteremia and endotoxin shock, we treated bacteremic patients with human antiserum to endotoxin (lipopolysaccharide) core. Antiserum was prepared by vaccinating healthy men with heat-killed Escherichia coli J5; this mutant lacks lipopolysaccharide oligosaccharide



全球贸易项目编号

货号GTIN
918644-1EA04065265147231